Position in KYMR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,274,585
+$6,045,163 QoQ
Shares Held
72,160
+169.6% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 273 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. KYMR ranks #35 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in KYMR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,274,585 | 72,160 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,229,422 | 26,767 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $5,173,508 | 66,489 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,814,652 | 32,061 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,115,917 | 25,571 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $613,991 | 22,433 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $882,605 | 21,939 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $684,012 | 14,452 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $429,212 | 14,379 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $524,930 | 13,058 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $274,712 | 10,790 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $504,193 | 36,273 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,222,170 | 53,161 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,252,666 | 42,277 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $50,843 | 2,037 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $76,346 | 3,507 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $180,418 | 9,163 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $781,523 | 18,467 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,864,446 | 29,366 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,084,212 | 35,482 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $69,354 | 1,430 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $34,546 | 889 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $668,794 | 10,787 | Shares | Defined | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||